Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

The conclusion is that certain surgeries can help people with gender dysphoria look more like their true gender and feel better.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The document concludes that facial feminization surgery improves psychological well-being and social acceptance for transgender individuals.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

A hair transplant using hair from the back of the head and pubic area was successful in creating a feminine hairline for a male-to-female transgender person.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Antiandrogens block male hormones and are not safe during pregnancy.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Significant facial gender transformation requires surgery, not nonsurgical methods.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Polygonum multiflorum can promote hair growth when taken orally or applied topically.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.